Selinexor
XPORT-MF-035
Phase 3 small_molecule active
Quick answer
Selinexor for Myelofibrosis is a Phase 3 program (small_molecule) at Karyopharm Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Karyopharm Therapeutics
- Indication
- Myelofibrosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active